ZA917692B - Substituted-4-amino-3-pyridinols,a process for their preparation and their use as medicaments - Google Patents

Substituted-4-amino-3-pyridinols,a process for their preparation and their use as medicaments

Info

Publication number
ZA917692B
ZA917692B ZA917692A ZA917692A ZA917692B ZA 917692 B ZA917692 B ZA 917692B ZA 917692 A ZA917692 A ZA 917692A ZA 917692 A ZA917692 A ZA 917692A ZA 917692 B ZA917692 B ZA 917692B
Authority
ZA
South Africa
Prior art keywords
loweralkyl
chem
hydrogen
preparation
pyridinols
Prior art date
Application number
ZA917692A
Other languages
English (en)
Inventor
Gregory Michael Shutske
Gregory M Shutske
John Dick Tomer
John D Tomer
John Gerard Jurcak
John G Jurcak
Kevin James Kapples
Kevin J Kapples
Nicholas Joseph Hrib
Nicholas J Hrib
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of ZA917692B publication Critical patent/ZA917692B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Surface Treatment Of Glass (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA917692A 1990-09-27 1991-09-26 Substituted-4-amino-3-pyridinols,a process for their preparation and their use as medicaments ZA917692B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58911390A 1990-09-27 1990-09-27

Publications (1)

Publication Number Publication Date
ZA917692B true ZA917692B (en) 1992-05-27

Family

ID=24356648

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA917692A ZA917692B (en) 1990-09-27 1991-09-26 Substituted-4-amino-3-pyridinols,a process for their preparation and their use as medicaments

Country Status (22)

Country Link
US (3) US5821239A (el)
EP (1) EP0477903B1 (el)
JP (1) JP3090511B2 (el)
KR (1) KR100215357B1 (el)
AT (1) ATE136297T1 (el)
AU (1) AU637720B2 (el)
CA (1) CA2052433C (el)
CZ (1) CZ282002B6 (el)
DE (1) DE69118470T2 (el)
DK (1) DK0477903T3 (el)
ES (1) ES2085940T3 (el)
FI (1) FI914504A (el)
GR (1) GR3019742T3 (el)
HU (1) HUT60247A (el)
IE (1) IE73874B1 (el)
IL (1) IL99581A (el)
NO (1) NO913778L (el)
NZ (1) NZ239935A (el)
PT (1) PT99073B (el)
TW (1) TW200462B (el)
YU (1) YU158591A (el)
ZA (1) ZA917692B (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
FR2813891B1 (fr) * 2000-09-14 2005-01-14 Immunotech Sa Reactif multifonctionnel pour erythrocytes mettant en jeu des carbamates et applications
DE10102791B4 (de) * 2001-01-22 2004-04-15 Ifm Electronic Gmbh Elektrischer Meßumformer
HUP0501011A3 (en) * 2001-12-14 2009-04-28 Novo Nordisk As Carbamates as hormone-sensitive lipase inhibitors, process for producing them, pharmaceutical compositions containing them and their use
KR100443983B1 (ko) 2002-01-15 2004-08-09 삼성전자주식회사 냉장고
US8007826B2 (en) * 2003-12-11 2011-08-30 Acorda Therapeutics, Inc. Sustained release aminopyridine composition
US8354437B2 (en) 2004-04-09 2013-01-15 Acorda Therapeutics, Inc. Method of using sustained release aminopyridine compositions
PL1849773T3 (pl) * 2005-02-17 2014-03-31 Astellas Pharma Inc Pochodne piperazyny do leczenia nietrzymania moczu i bólu
AU2009291781A1 (en) * 2008-09-10 2010-03-18 Acorda Therapeutics, Inc. Methods of using sustained release aminopyridine compositions
BR112012019923A2 (pt) 2010-02-09 2016-08-09 Univ Johns Hopkins métodos e composições para melhorar a função cognitiva
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
GEP201706739B (en) 2012-12-13 2017-09-25 H Lundbeck As Compositions comprising vortioxetine and donepezil
EP2968220B1 (en) 2013-03-15 2021-05-05 Agenebio, Inc. Methods and compositions for improving cognitive function
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
CN107810002B (zh) 2015-05-22 2021-01-05 艾吉因生物股份有限公司 左乙拉西坦的延时释放药物组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179563A (en) * 1978-05-19 1979-12-18 Warner-Lambert Company 3-Aryloxy-substituted-aminopyridines and methods for their production
US4734275A (en) * 1983-08-19 1988-03-29 Research Corporation Anti-curare agents
DE3514073A1 (de) * 1985-04-18 1986-10-23 Hoechst Ag, 6230 Frankfurt Mehrfach substituierte pyridin-1-oxide, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
US4735958A (en) * 1986-12-22 1988-04-05 Warner-Lambert Company Trans-6-[2-[2-(substituted-phenyl)-3- (or 4-) heteroaryl-5-substituted-1H-pyrrol-1-yl]-ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one inhibitors of cholesterol biosynthesis
US4831044A (en) * 1987-10-29 1989-05-16 Ici Americas Inc. Fungicidal pyridyl cyclopropane carboxamidines
US4994473A (en) * 1987-11-17 1991-02-19 Ici Americas Inc. Pyridyl containing insecticides
EP0361489A3 (en) * 1988-09-30 1991-06-12 Chugai Seiyaku Kabushiki Kaisha Novel 3,4-diaminoquinoline and pyridine compounds
KR0156241B1 (ko) * 1988-11-16 1998-11-16 도날드 알.토센 하이드록시-1,2,3,4-테트라하이드로아미노아크리딘, 이의 제조방법 및 이를 함유하는 약제학적 조성물
US4931457B1 (en) * 1989-06-28 1993-11-16 Hoechst-Roussel Pharmaceuticals Incorporated Naphthylamino-and naphthyloxy-pyridineamin compounds useful as topical antiinflammatory agents for the treatment of skin disorders

Also Published As

Publication number Publication date
IL99581A0 (en) 1992-08-18
GR3019742T3 (en) 1996-07-31
NO913778L (no) 1992-03-30
AU8475691A (en) 1992-04-02
IE73874B1 (en) 1997-07-02
PT99073B (pt) 1999-02-26
DE69118470D1 (de) 1996-05-09
EP0477903A2 (en) 1992-04-01
DK0477903T3 (da) 1996-07-29
FI914504A (fi) 1992-03-28
FI914504A0 (fi) 1991-09-25
EP0477903B1 (en) 1996-04-03
US5821239A (en) 1998-10-13
IE913389A1 (en) 1992-04-08
AU637720B2 (en) 1993-06-03
CA2052433A1 (en) 1992-03-28
CZ282002B6 (cs) 1997-04-16
ATE136297T1 (de) 1996-04-15
TW200462B (el) 1993-02-21
KR920006318A (ko) 1992-04-27
IL99581A (en) 1995-07-31
DE69118470T2 (de) 1996-09-19
PT99073A (pt) 1992-08-31
US5866565A (en) 1999-02-02
JP3090511B2 (ja) 2000-09-25
ES2085940T3 (es) 1996-06-16
HU913075D0 (en) 1992-01-28
YU158591A (sh) 1994-12-28
HUT60247A (en) 1992-08-28
CA2052433C (en) 2003-04-15
NO913778D0 (no) 1991-09-26
CS293691A3 (en) 1992-04-15
EP0477903A3 (en) 1992-08-05
US5869480A (en) 1999-02-09
NZ239935A (en) 1995-07-26
JPH04261157A (ja) 1992-09-17
KR100215357B1 (ko) 1999-08-16

Similar Documents

Publication Publication Date Title
GR3019742T3 (en) Substituted-4-amino-3-pyridinols, a process for their preparation and their use as medicaments
GR3019468T3 (en) 4- and 6-Carbamates related to physostigmine, a process and intermediates for their preparation and their use as medicaments
GR3026231T3 (en) 3-aminopiperidine derivatives and related nitrogen containing heterocycles.
HU9201887D0 (en) Process for the production of //aralkyl-piperidine-4-yl/-methyl/-2a,3,4,5-tetrahydro-1-/2h/-acenaphtylene-1-on derivatives and of medical preparations containing them as active agents
GR3005461T3 (el)
ES2102774T3 (es) Indolsulfonamidas como agentes antitumorales.